F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump

The Food and Drug Administration has granted emergency authorization for the experimental antibody treatment given to President Trump shortly after he was diagnosed with Covid-19, giving doctors another option to treat Covid-19 patients as cases across the country continue to rise. The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise […]

Read more

Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern

The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron. By Katherine J. Wu and Katie Thomas A government-sponsored clinical trial that is testing an antibody treatment for Covid-19 developed by the drugmaker Eli Lilly has been paused because of a “potential safety concern,” according to emails that government officials sent on Tuesday to researchers […]

Read more

Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?

The Food and Drug Administration recently approved two transformative new treatments for sickle-cell disease, the first in 20 years. But the drugs are wildly expensive, renewing troubling questions about access to cutting-edge medicines. Adakveo, made by Novartis, can prevent episodes of nearly unbearable pain that occur when malformed blood cells get stuck in blood vessels. Approved only for patients aged […]

Read more

Zantac Has Low Levels of a Cancer-Causing Chemical, the F.D.A. Says

The Food and Drug Administration said on Friday that it had detected low levels of a cancer-causing contaminant in samples of heartburn medicines containing the drug commonly known as Zantac. It was advising patients who take over-the-counter versions to consider switching to a different medication. But no recalls have been initiated, and the agency said patients who take prescription versions […]

Read more

Promising treatment for an incurable, deadly kidney disease

A potential treatment for polycystic kidney disease — a genetic disorder that causes the kidneys to swell with multiple cysts and can eventually lead to organ failure — has shown promising results in animal testing. A study describing the drug’s development and testing appears today in Nature Communications. The study shows an approximately 50 percent reduction in kidney size in […]

Read more

Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets

Twenty years ago, the fight against cancer seemed as if it were about to take a dramatic turn. Traditionally, cancer doctors fought the disease with crude weapons, often simply poisoning fast-growing cells whether they were cancerous or healthy. But then a team of researchers hit on a new strategy: drugs targeting proteins produced by cancer cells that seemed necessary to […]

Read more

Popular pain medication associated with greater risk of hypoglycemia: Tramadol, an opioid, is widely used to treat moderate or severe pain, but patients may be at risk of low blood sugar levels

Since its approval in 1995, the opioid tramadol (marketed as ConZip and Ultram) has become a widely prescribed remedy for osteoarthritis and other painful indications, in part because it presents a lesser risk for some side effects and has a lower abuse potential when compared to other opioids. It is currently ranked among the top five prescribed opioids and top […]

Read more

Charcoal-based drug delivery system improves efficacy of common herpes drug

A study led by researchers from the University of Illinois at Chicago has found that combining acyclovir — a commonly prescribed topical herpes medication — with particles of activated carbon improves efficacy of the drug. This new approach allows for less frequent dosing and overall course of treatment while providing some protection from infection by the virus as well, opening […]

Read more
1 2 3